Neuroendocrine Tumors
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide [Phase 4]
Phase 4 trial comparing patient experience on octreotide long-acting release versus lanreotide in neuroendocrine tumor patients; results hav…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. [NA]
This is a prospective study (EQUITY GI) to improve quality, inclusivity, and trial participation for Black patients with gastrointestinal ca…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study [Phase 1]
Phase 1 study evaluating HBM4003 in combination with toripalimab in patients with advanced neuroendocrine tumors and other solid tumors, inc…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors [Phase 1]
Phase 1 trial of Pelcitoclax (APG-1252) for Neuroendocrine Tumors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: TARGETed Therapy Drug MONITOring in DIGestive Oncology [NA]
UNICANCER-sponsored clinical trial is recruiting a targeted therapy monitoring study in digestive oncology, including metastatic colorectal …
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies [Phase 1, Phase 2]
Memorial Sloan Kettering Cancer Center completed a Phase 1/Phase 2 clinical trial evaluating the 18F-MFBG imaging agent for evaluating neuro…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) [Phase 2]
A Phase 2 trial (QUADRUPLE THREAT) evaluated RRx-001 in small cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and epith…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours [Phase 1]
Phase 1 clinical trial evaluating a PARP inhibitor combined with 177Lu-DOTA-Octreotate peptide receptor radionuclide therapy in patients wit…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Clinical Application of the J-PET Scanner Prototype
Clinical trial update announcing recruitment for a prototype J-PET scanner. The study targets imaging in prostate cancer, benign prostatic h…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
A multicenter retrospective study on prognostic and predictive factors in neuroendocrine tumors, sponsored by the Latin American Cooperative…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial updating the validation of 99mTc-EDDA-HYNIC-TOC diagnostic kits for neuroendocrine tumors (completed).
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study
The NEMESIs-study evaluates a methylation-based classifier for neuroendocrine tumors and is reported as completed.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: The Role of Intraoperative Hepatic Ultrasonography in Gastrointestinal or Pancreatic Neuroendocrine Tumor
This clinical trial update discusses the use of intraoperative hepatic ultrasonography during surgery for gastrointestinal or pancreatic neu…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors [EARLY_Phase 1]
This document reports on the Phase 1 imaging study of the PET radiotracer [18F]3F-PHPG in patients with neuroendocrine tumors. It focuses on…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy [Phase 1, Phase 2]
Clinical trial update on AdVince, a recombinant adenovirus, evaluating safety and preliminary efficacy in patients with neuroendocrine tumor…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial registry entry for a Phase 1/2a study of 23ME-00610 in patients with advanced solid malignancies, including several gynecolog…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics [NA]
Clinical trial registry entry describing an ongoing targeted-agent evaluation in digestive cancers in China based on molecular characteristi…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors [Phase 2]
This update reports results from a Phase 2 study evaluating the combination of LEE011 (ribociclib) and Everolimus in patients with advanced …
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Clinical-pathological Evaluation of Pit-NETs
This clinical trial update describes a study evaluating the clinical and pathological features of pituitary neuroendocrine tumors (Pit-NETs)…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors [Phase 2]
Phase 2 trial update evaluating the optimal interval between cycles of Lutathera (177Lu-DOTATATE) peptide receptor radionuclide therapy in S…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: "Receptor Radionuclide Therapy With 177Lu-DOTATOC [Phase 2]
A Phase 2 trial evaluating receptor radionuclide therapy with 177Lu-DOTATOC for neuroendocrine tumors, including paraganglioma and pheochrom…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers [Phase 2]
Phase II study evaluating the combination of ipilimumab and nivolumab for rare cancers has completed.
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: 68Ga-DOTA-TATE PET/CT Imaging in NETs [Phase 3]
A Phase 3 clinical trial is evaluating 68Ga-DOTA-TATE PET/CT imaging for neuroendocrine tumors and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Investigation of the Effects of Diet on the Measurement of Plasma Chromogranin in NET Patients [NA]
This document reports the completion of a clinical trial evaluating whether diet affects plasma chromogranin measurements in neuroendocrine …